GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » CQ Pharmaceutical Holding Co Ltd (SZSE:000950) » Definitions » Capex-to-Revenue

CQ Pharmaceutical Holding Co (SZSE:000950) Capex-to-Revenue : 0.00 (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is CQ Pharmaceutical Holding Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

CQ Pharmaceutical Holding Co's Capital Expenditure for the three months ended in Mar. 2024 was ¥-47.92 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥19,624.28 Mil.

Hence, CQ Pharmaceutical Holding Co's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.00.


CQ Pharmaceutical Holding Co Capex-to-Revenue Historical Data

The historical data trend for CQ Pharmaceutical Holding Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CQ Pharmaceutical Holding Co Capex-to-Revenue Chart

CQ Pharmaceutical Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.01 0.01 - -

CQ Pharmaceutical Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.01 -

Competitive Comparison of CQ Pharmaceutical Holding Co's Capex-to-Revenue

For the Medical Distribution subindustry, CQ Pharmaceutical Holding Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CQ Pharmaceutical Holding Co's Capex-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, CQ Pharmaceutical Holding Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where CQ Pharmaceutical Holding Co's Capex-to-Revenue falls into.



CQ Pharmaceutical Holding Co Capex-to-Revenue Calculation

CQ Pharmaceutical Holding Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-244.407) / 80119.107
=0.00

CQ Pharmaceutical Holding Co's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-47.921) / 19624.283
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CQ Pharmaceutical Holding Co  (SZSE:000950) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


CQ Pharmaceutical Holding Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of CQ Pharmaceutical Holding Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CQ Pharmaceutical Holding Co (SZSE:000950) Business Description

Traded in Other Exchanges
N/A
Address
333 Jinshi Avenue, Yubei District, Chongqing, CHN, 400010
CQ Pharmaceutical Holding Co Ltd distributes pharmaceutical products. It is the fixed-point reserve unit for drug and medical equipment of the central and Chongqing industries. The pharmaceutical business sector covers hospitals, pharmaceuticals, healthcare products, hospital sales, commercial wholesale, retail chains, terminal distribution, warehousing logistics and supply chain value-added services. Geographically, the group operates through China.

CQ Pharmaceutical Holding Co (SZSE:000950) Headlines

No Headlines